It's quite incredible. This chemical appears to have a safety profile comparable with the coronavirus itself, and yet the stock market appears to anticipate a possibility that people will get injected with it en masse.
That's because the one thing certainly Moderna has been good at is hype. Many biologists have been pretty skeptical about an mRNA vaccine and yet Moderna has been riding high.